home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Adaptive by Design: How RTSM Powers Early-Phase Clinical Trial Success

 
  April 01, 2025  
     
 
Xtalks, Online
2025-05-01


Early-phase clinical trials require precision and agility. Yet, managing protocol changes, patient cohorts and investigational product (IP) supply can quickly become a logistical challenge.

Adaptive trials require faster decision-making and seamless execution. Without the right randomization and trial supply management (RTSM), teams jeopardize both study success and patient safety.

The key to overcoming these challenges is not just automation—it is adaptability. A configurable RTSM evolves with your trial to mitigate risk, improve compliance and prevent costly supply disruptions. When integrated with an eClinical platform, RTSM enhances workflows and efficiency, ensuring trials stay on track.

This webinar explores why a flexible RTSM is essential for early-phase success—and how Medrio’s unified approach makes a difference.

Register for this webinar today to learn how a unified, configurable RTSM solution can drive early-phase trial success.

Keywords: Clinical Trials, Compliance, Clinical Research, CRO, Patient Safety, Regulatory Compliance, Logistics, IRT, Sponsors, Early-Phase Trials, Early Phase Clinical Trials, CT Logistics
 
 
Organized by: Xtalks
Invited Speakers: Ian Davison, RTSM Subject Matter Expert, Medrio
Naji Hamim, RTSM Product Owner, Medrio
 
Deadline for Abstracts: 2025-05-01
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2025 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.